439 related articles for article (PubMed ID: 9875221)
1. A mouse model for beta cell-specific ablation of target gene(s) using the Cre-loxP system.
Ray MK; Fagan SP; Moldovan S; DeMayo FJ; Brunicardi FC
Biochem Biophys Res Commun; 1998 Dec; 253(1):65-9. PubMed ID: 9875221
[TBL] [Abstract][Full Text] [Related]
2. Beta cell-specific ablation of target gene using Cre-loxP system in transgenic mice.
Ray MK; Fagan SP; Moldovan S; DeMayo FJ; Brunicardi FC
J Surg Res; 1999 Jun; 84(2):199-203. PubMed ID: 10357920
[TBL] [Abstract][Full Text] [Related]
3. Mouse alpha1(I)-collagen promoter is the best known promoter to drive efficient Cre recombinase expression in osteoblast.
Dacquin R; Starbuck M; Schinke T; Karsenty G
Dev Dyn; 2002 Jun; 224(2):245-51. PubMed ID: 12112477
[TBL] [Abstract][Full Text] [Related]
4. Endothelium-specific Cre recombinase activity in flk-1-Cre transgenic mice.
Licht AH; Raab S; Hofmann U; Breier G
Dev Dyn; 2004 Feb; 229(2):312-8. PubMed ID: 14745955
[TBL] [Abstract][Full Text] [Related]
5. Development of a transgenic mouse model using rat insulin promoter to drive the expression of CRE recombinase in a tissue-specific manner.
Ray MK; Fagan SP; Moldovan S; DeMayo FJ; Brunicardi FC
Int J Pancreatol; 1999 Jun; 25(3):157-63. PubMed ID: 10453417
[TBL] [Abstract][Full Text] [Related]
6. Specific Cre/Lox recombination in the mouse proximal tubule.
Rubera I; Poujeol C; Bertin G; Hasseine L; Counillon L; Poujeol P; Tauc M
J Am Soc Nephrol; 2004 Aug; 15(8):2050-6. PubMed ID: 15284291
[TBL] [Abstract][Full Text] [Related]
7. Tie2-Cre transgenic mice: a new model for endothelial cell-lineage analysis in vivo.
Kisanuki YY; Hammer RE; Miyazaki J; Williams SC; Richardson JA; Yanagisawa M
Dev Biol; 2001 Feb; 230(2):230-42. PubMed ID: 11161575
[TBL] [Abstract][Full Text] [Related]
8. Site- and time-specific gene targeting in the mouse.
Metzger D; Chambon P
Methods; 2001 May; 24(1):71-80. PubMed ID: 11327805
[TBL] [Abstract][Full Text] [Related]
9. Alterations of pancreatic beta-cell mass and islet number due to Ins2-controlled expression of Cre recombinase: RIP-Cre revisited; part 2.
Pomplun D; Florian S; Schulz T; Pfeiffer AF; Ristow M
Horm Metab Res; 2007 May; 39(5):336-40. PubMed ID: 17533574
[TBL] [Abstract][Full Text] [Related]
10. Cre recombinase-mediated gene targeting of mesenchymal cells.
Florin L; Alter H; Gröne HJ; Szabowski A; Schütz G; Angel P
Genesis; 2004 Mar; 38(3):139-44. PubMed ID: 15048811
[TBL] [Abstract][Full Text] [Related]
11. A novel transgenic technique that allows specific marking of the neural crest cell lineage in mice.
Yamauchi Y; Abe K; Mantani A; Hitoshi Y; Suzuki M; Osuzu F; Kuratani S; Yamamura K
Dev Biol; 1999 Aug; 212(1):191-203. PubMed ID: 10419695
[TBL] [Abstract][Full Text] [Related]
12. Temporal, spatial, and cell type-specific control of Cre-mediated DNA recombination in transgenic mice.
Utomo AR; Nikitin AY; Lee WH
Nat Biotechnol; 1999 Nov; 17(11):1091-6. PubMed ID: 10545915
[TBL] [Abstract][Full Text] [Related]
13. A transgenic mouse that targets the expression of Cre recombinase in pancreatic tissue.
Zhou J; Cheng X; Lu YX; Huang CF; Yang X
Sheng Wu Gong Cheng Xue Bao; 2002 May; 18(3):286-90. PubMed ID: 12192858
[TBL] [Abstract][Full Text] [Related]
14. Transgenic mice engineered to target Cre/loxP-mediated DNA recombination into catecholaminergic neurons.
Gelman DM; Noaín D; Avale ME; Otero V; Low MJ; Rubinstein M
Genesis; 2003 Aug; 36(4):196-202. PubMed ID: 12929090
[TBL] [Abstract][Full Text] [Related]
15. Z/EG, a double reporter mouse line that expresses enhanced green fluorescent protein upon Cre-mediated excision.
Novak A; Guo C; Yang W; Nagy A; Lobe CG
Genesis; 2000; 28(3-4):147-55. PubMed ID: 11105057
[TBL] [Abstract][Full Text] [Related]
16. Odontoblast-specific expression of cre recombinase successfully deletes gene segments flanked by loxP sites in mouse teeth.
Sreenath TL; Cho A; Thyagarajan T; Kulkarni AB
Genesis; 2003 Feb; 35(2):94-9. PubMed ID: 12533791
[TBL] [Abstract][Full Text] [Related]
17. An efficient system for tissue-specific overexpression of transgenes in podocytes in vivo.
Moeller MJ; Soofi A; Sanden S; Floege J; Kriz W; Holzman LB
Am J Physiol Renal Physiol; 2005 Aug; 289(2):F481-8. PubMed ID: 15784842
[TBL] [Abstract][Full Text] [Related]
18. Z/AP, a double reporter for cre-mediated recombination.
Lobe CG; Koop KE; Kreppner W; Lomeli H; Gertsenstein M; Nagy A
Dev Biol; 1999 Apr; 208(2):281-92. PubMed ID: 10191045
[TBL] [Abstract][Full Text] [Related]
19. Thyrocyte-specific expression of Cre recombinase in transgenic mice.
Kusakabe T; Kawaguchi A; Kawaguchi R; Feigenbaum L; Kimura S
Genesis; 2004 Jul; 39(3):212-6. PubMed ID: 15282748
[TBL] [Abstract][Full Text] [Related]
20. Investigation of the fate of Sry-expressing cells using an in vivo Cre/loxP system.
Ito M; Yokouchi K; Yoshida K; Kano K; Naito K; Miyazaki J; Tojo H
Dev Growth Differ; 2006 Jan; 48(1):41-7. PubMed ID: 16466392
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
